Title |
The autoimmune lymphoproliferative syndrome: an experiment of nature involving lymphocyte apoptosis
|
---|---|
Published in |
Immunologic Research, September 2007
|
DOI | 10.1007/s12026-007-8001-1 |
Pubmed ID | |
Authors |
Thomas A. Fleisher |
Abstract |
Autoimmune lymphproliferative syndrome (ALPS) is a human disorder that has been characterized in the past two decades at both a functional and a genetic level. The underlying basis for this disorder is a defect in lymphocyte apoptosis that alters immune homeostasis resulting in an expansion of a normally rare circulating lymphocyte, the alpha beta double negative T cell. The abnormality in Fas mediated apoptosis underlying ALPS serves as a risk factor for autoimmunity involving blood cells and the development of lymphoma. There remain patients with a diagnosis of ALPS but without a defined genetic defect and current investigations are focusing on fully characterizing this patient subgroup. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 4% |
Germany | 1 | 4% |
Unknown | 26 | 93% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 7 | 25% |
Student > Ph. D. Student | 4 | 14% |
Student > Doctoral Student | 4 | 14% |
Student > Master | 3 | 11% |
Student > Bachelor | 2 | 7% |
Other | 7 | 25% |
Unknown | 1 | 4% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 13 | 46% |
Agricultural and Biological Sciences | 8 | 29% |
Biochemistry, Genetics and Molecular Biology | 3 | 11% |
Immunology and Microbiology | 2 | 7% |
Neuroscience | 1 | 4% |
Other | 0 | 0% |
Unknown | 1 | 4% |